Sepsis / Septic Shock

1.    Mackay F et al. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007;19:327-36.
2.    Falini B et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995;85:1-14.
3.     Klimiuk PA et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 2002;61:804–809.
5.     Littler AJ et al. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 1997;36:164-9.
6. McInnes IB et al. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-42.
7. Koch AE et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. Ann Rheum Dis 1999;58:297-302.
8. Ellingsen T et al. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
J Rheumatol 2001;28:41-6.
9. Wållberg-Jonsson S et al. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
Scand J Rheumatol 2008;37:1-5.
10. Hatano Y et al. Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis. Ann Rheum Dis 1999;58:297-302.
11. Asanuma Y et al. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis 2007;195:e135-41.
12. Saidenberg-Kermanac'h N et al. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 2004;71:9-13.
13. Rodríguez-García MI et al. Annexin V autoantibodies in rheumatoid arthritis. Ann Rheum Dis 1996 Dec;55(12):895-900.
14. Cordero OJ et al. Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol Int 2001;21:69-74.
15. Michel J et al. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol 1998;28:290-5.
16. Kim WU et al. Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis. Arthritis Res Ther 2007;9:R42.
17. Saito S et al. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J Rheumatol 2008;35:1932-43.
18. Goldbach-Mansky R et al. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. Ann Rheum Dis 2005;64:715-21.
19. Tak PP et al. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 1999;116:366-70.
20 Turesson C et al. Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 2001;40:1346-54.
21. Mino T et al. Interleukin-1alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis Rheum 1998;41:2004-13.
22. Ertenli I et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol 1998;25:1054-8.
23. Bell MC et al. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention. J Rheumatol 2000;27:332-8.
24. Chabaud M et al. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998;161:409-14.
25. Shinozaki M et al. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA. Mod Rheumatol 2007;17:403-8.
26. Jovanovic DV et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 2000;43:1134-44.
27. Tchetverikov I et al. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 2003;62:1094-9.